RESEARCH TRIANGLE PARK (North Carolina) - GLAXOSMITHKLINE, the world's second-largest drugmaker, said Friday it has boosted production of antiviral medication as the US government reported two dozen additional cases of swine flu.
The London-based company said it is ramping up operations to be able to produce about 5 million packs of Relenza per month, but it will take 12 to 14 weeks to get to that level.